covid-19 rESOURCES

Updated: January 2023 

These resources will be updated as the COVID-19 situation evolves in Chicago and across the United States. ​

Northwestern Medicine Treatment Options

• Clinical Pathway – ED, Floor and ICU Patients
• Outpatient Therapy Guidance – Ambulatory
• Outpatient Treatment Update | Updated August 2022
• Clinical Trials

No Longer Recommended 

• Bebtelovimab EUA Removal Information
• Evusheld EUA Removal Information
• Bebtelovimab & Evusheld (tixagevimab/cilgavimab) are no longer recommended at Northwestern Medicine as COVID-19 treatment & prophylaxis, respectively, in any patients due to predominance of resistant COVID-19 subvariants. See the CDC discussion for more details.

​
Guidelines and Resources

• ​NIH COVID-19 Treatment Guidelines
• ​IDSA COVID-19 Treatment Guidelines
• CDC COVID-19 Therapeutics Update 12.2022

​
Paxlovid

• EUA Information for Healthcare Providers
• Patient EUA Fact Sheet
• Eligibility and Prescriber Information FAQ

Drug Interactions Guidance

• University of Liverpool Drug-Drug Interaction Checker
• IDSA Paxlovid Drug Interactions Guidance

Molnupiravir

• EUA Information for Healthcare Providers
• ​Patient EUA Fact Sheet​

Therapy Locators and Availability
​

• HHS COVID-19 Public Outpatient Therapeutic Locator
• ​IDPH COVID-19 Outpatient Therapy Locator
• IL-6 Inhibitor COVID-19 Treatment Allocation Plan (PDF)

---

NORTHWESTERN MEDICINE COVID-19 PATIENT INFORMATION